Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Collegium Pharmaceutical, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
COLL
Nasdaq
2830
www.collegiumpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Collegium Pharmaceutical, Inc.
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pressure
- Mar 13th, 2026 7:14 pm
3 Healthcare Stocks Walking a Fine Line
- Mar 13th, 2026 3:46 am
Collegium Pharmaceutical (COLL) Surged Following Record Quarterly Results
- Mar 10th, 2026 7:04 am
Collegium to Present New Real-World Data at PainConnect 2026
- Mar 5th, 2026 6:00 am
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
- Mar 3rd, 2026 6:00 am
Collegium to Participate in Upcoming Investor Conferences
- Mar 2nd, 2026 6:00 am
Why Collegium Pharmaceutical (COLL) Is Down 7.4% After Reaffirming 2026 Revenue Guidance Despite Earnings Miss
- Feb 27th, 2026 10:14 pm
Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today
- Feb 27th, 2026 3:26 pm
Collegium Pharmaceutical, Inc. Q4 2025 Earnings Call Summary
- Feb 26th, 2026 2:32 pm
Collegium Pharmaceutical Inc (COLL) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ...
- Feb 26th, 2026 2:13 pm
Collegium (COLL) Q4 2025 Earnings Call Transcript
- Feb 26th, 2026 1:10 pm
Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say
- Feb 26th, 2026 10:30 am
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
- Feb 26th, 2026 10:15 am
Collegium Pharmaceutical Q4 Earnings Call Highlights
- Feb 26th, 2026 7:16 am
Collegium Pharmaceutical: Q4 Earnings Snapshot
- Feb 26th, 2026 5:53 am
Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
- Feb 26th, 2026 5:36 am
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
- Feb 26th, 2026 5:30 am
Collegium Partnership With Boston Legacy FC Backs Sensory Inclusion And ESG Story
- Feb 25th, 2026 1:11 am
Collegium Pharmaceutical (COLL) Q4 Earnings: What To Expect
- Feb 24th, 2026 9:06 pm
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?
- Feb 24th, 2026 8:00 am
Scroll